Navigation Links
NeoStem to Present at Two Investor Conferences Thursday, November 18, 2010
Date:11/18/2010

NEW YORK, Nov. 18, 2010 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that Dr. Robin Smith, the Company's Chairman and CEO, will present at the 2010 Maxim Group Growth Conference this morning and at the Proactive Investors One2One Investor Forum this evening. Both events will be held in New York, NY.

The 2010 Maxim Group Growth Conference will be held in Carnegie/Alvin room at the Grand Hyatt Hotel in New York City, NY.  Dr. Smith is scheduled to make a presentation from 10-10:30 a.m. today, November 18, 2010 and will be available to meet with investors throughout the conference.  The Proactive Investors One2One Investor Forum will be held this evening in the Whitney Room at the Intercontinental New York Barclay Hotel in New York, NY.  Dr. Smith is scheduled to present 6:30 p.m. and will host a question and answer session after her formal presentation.

"I look forward to the opportunity to showcase NeoStem for investors, industry experts and those from the scientific community at both these events today," said Dr. Robin Smith.  "We are proud of the growth that NeoStem is experiencing at present and the future opportunities that are open to NeoStem in the expanding adult, autologous stem cell therapy market."

About NeoStem, Inc.NeoStem, Inc. is engaged in the development of stem cell-based therapies and building of a network of adult stem cell collection centers in the U.S. and China that are focused on enabling people to donate and store their own (autologous) stem cells for their personal use in times of future medical need.  The Company is also the licensee of various stem cell technologies, including a worldwide exclusive license to VSEL™ Technology which uses very small embryonic-like stem
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeoStem Announces Pricing of Concurrent Offerings for $19 Million in Gross Proceeds
2. NeoStem Provides Third Quarter Update
3. NeoStem to Present at LifeTech Capital Miami Medical Investors Conference
4. Local Chinese Government Authorities Approve Pricing and Reimbursement for NeoStems Licensed Adult Stem Cell Treatments for Orthopedic Applications in China
5. NeoStem to Present at Cell Therapy Industry Summit to be held on November 3-5, 2010 in Carlsbad, California
6. NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement
7. NeoStem Comments on Recent Court Ruling Blocking the Federal Governments Funding of Embryonic Stem Cell Research
8. NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board
9. NeoStem Pharmaceutical Subsidiary Announces Two cGMP Lines are Now Fully Operational in New Facility
10. NeoStem, Inc. Officially Launches Adult Stem Cell Collection Center and R&D Laboratory in Cambridge, Massachusetts
11. NeoStem Announces Warrant Exercise by Principal Shareholder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... Congressional Leaders to Introduce Legislation , WASHINGTON , ... Congressional Network (ACPCN) will join congressional leaders tomorrow to ... Savings Act." The bill by U.S. Rep. G.K. ... management (PBM) companies for medications. , "Congress is prepared ...
... AMD LASERS, the world leader in comprehensive and affordable ... Waclawik as Chief Operating Officer. In this newly created ... operations, procurement, production, quality assurance, and general financial oversight ... effort on the next-generation of product development in order ...
Cached Medicine Technology:Pharmacists Work with Congress to Address PBM Abuses 2AMD LASERS Announces the Addition of Bart Waclawik, New Chief Operating Officer 2
(Date:4/23/2014)... by a researcher from the Cancer Science Institute of ... has identified the cancer specific stem cell which causes ... developing new drugs for the treatment of this disease ... led by Dr Chan Shing Leng, Research Assistant Professor ... a cancer-specific variant of a cell surface protein, CD44v8-10, ...
(Date:4/23/2014)... may prevent the depletion of self-control, according to research ... the Association for Psychological Science. , Self-control can be ... focus attention on a boring textbook are hard things ... this difficulty: Exerting self-control for a long period seems ... subsequent tasks. , "It is as if self-control is ...
(Date:4/22/2014)... the New Jersey Institute of Technology (NJIT) today ... the launch of the New Jersey Innovation Institute ... model for business innovation through the leveraging of ... U.S. Senator Cory Booker, Panasonic Corp. of North ... Lieutenant Governor Kim Guadagno, New Jersey Secretary of ...
(Date:4/22/2014)... 2014 Researchers at UT Southwestern Medical Center are ... depression . , A team of physician-scientists at ... ghrelin (a hormone with natural anti-depressant properties) works inside ... new treatment for depression in the form of a ... study, published online in April,s issue of Molecular ...
(Date:4/22/2014)... 22, 2014) The International Communication Association will ... Seattle, Washington. The theme of the 2014 conference ... a networked and digital society. , Featuring over ... over 2,200 Communication scholars representing over 40 countries, ... communication conference in the world. This year,s conference ...
Breaking Medicine News(10 mins):Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:ADHD drug may help preserve our self-control resources 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2
... 4 (HealthDay News) -- The quality of family mealtimes ... research suggests. In the study, U.S. researchers observed ... children aged 5 to 12 with persistent asthma. ... or in a particular season, children with persistent asthma ...
... , FRIDAY, Feb. 4 (HealthDay News) -- The death of ... typically seen directed toward live infants, but it,s unclear whether ... may help improve understanding of how chimpanzees, one of humans, ... study authors noted. In the study, the researchers ...
... News) -- Safety labels that outline concerns about medications, ... within drug categories, a new study suggests. These ... a single class of drugs, according to a team ... team also advised that supplemental warnings (for example, following ...
... is blamed on a failure of innovative drive in the ... of venture capital to invest in early stage research, or ... , A research centre funded by the Economic and Social ... industry regulatory system must be an important part of the ...
... Gordon HealthDay Reporter , THURSDAY, Feb. 3 ... reduce symptoms of attention-deficit hyperactivity disorder (ADHD) in young ... the ages of 4 and 8 were placed on ... ADHD symptoms diminished in 78 percent of them. And, ...
... THURSDAY, Feb. 3 (HealthDay News) -- Although blacks make up only ... of all diagnosed cases of HIV, federal health officials reported Thursday. ... times that of whites, and the rate for black women is ... data from 37 states by the U.S. Centers for Disease Control ...
Cached Medicine News:Health News:Quality of Family Mealtimes May Affect Kids' Asthma 2Health News:'Black Box' Drug Warning Labels Applied Inconsistently: Study 2Health News:Tipping points -- the future of the pharmaceutical industry 2Health News:Restrictive Diet May Reduce ADHD Symptoms 2Health News:Restrictive Diet May Reduce ADHD Symptoms 3Health News:Restrictive Diet May Reduce ADHD Symptoms 4Health News: Burden of HIV Highest for Blacks, CDC Reports 2Health News: Burden of HIV Highest for Blacks, CDC Reports 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: